Related Experiment Videos

[Cardiolipin antibodies in pregnancy of high risk]

Insights

Cardiolipin antibodies (CAb) are linked to adverse outcomes in high-risk pregnancies, including fetal death and intrauterine growth restriction. These antibodies may contribute to complications such as hypertension and recurrent miscarriages.

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Perinatal Medicine

Background:

  • High-risk pregnancies present complex challenges in perinatal care.
  • Cardiolipin antibodies (CAb) are implicated in various autoimmune and thrombotic conditions.

Purpose of the Study:

  • To investigate the prevalence and significance of cardiolipin IgG and IgM antibodies (CAb) in high-risk pregnancies.
  • To determine the association between CAb and specific gestational complications.

Main Methods:

  • Study included 116 high-risk pregnant women at a regional perinatal center.
  • Cardiolipin IgG and IgM antibodies (CAb) were assessed.
  • Association with outcomes like fetal death, hypertension, abortions, infertility, gestosis, and growth retardation was analyzed.

Main Results:

  • CAb were found in 50% of cases with antenatal fetal death.
  • Prevalence of CAb was noted in 21.4% with hypertension, 20% with habitual abortions, 20% with infertility history, and 15.2% with gestational gestosis.
  • Intrauterine growth retardation was associated with CAb in 33.3% of cases.
  • CAb were also observed in women with high uterine vascular resistance.

Conclusions:

  • Cardiolipin antibodies (CAb) play a role in the development of gestational complications in high-risk pregnancies.
  • Elevated CAb levels are associated with adverse pregnancy outcomes, including fetal demise and growth restriction.
  • Further research is warranted to elucidate the precise mechanisms and guide clinical management.

Related Concept Videos